CUI JINGRONG JEAN (Chief Scientific Officer) sold 1.3% of their position (11.50K shares) of TURNING POINT THERAPEUTICS, INC. on the open market
Open‑market sale worth $610.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/17/2020ACC: 0001209191-20-004085
DirectorOfficer10% Owner· Chief Scientific Officer
Since Apr 2019
-11.50K
Net shares
Net seller
$610.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
11.50K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−9.90K
Price / share
$53.03
Trade value
$525K
% of position
1.1%
1/15/2020
880.72K→870.82K
Common Stock
Indirect
Shares
−1.60K
Price / share
$53.66
Trade value
$85.86K
% of position
0.2%
1/15/2020
870.82K→869.22K
Total
Net shares
−11.50K
Net value
-$610.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 1/15/2020 | S · Sale | −9.90K | $53.03 | $525K | 1.1% | 880.72K | 870.82K |
| Common Stock Indirect | 1/15/2020 | S · Sale | −1.60K | $53.66 | $85.86K | 0.2% | 870.82K | 869.22K |
| Total | −11.50K | -$610.85K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned1.30M
Total
1.30M direct1.30M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.30M | Direct |
| Total | 1.30M | 1.30M direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported